Launch-Ready Therapeutic Specialty Rep

Inizio Engage; Alameda (CA); On-site; USD 125,000 - 150,000; Full time

Benefits offered by this job

Bonus eligibility

Health insurance

Retirement benefits

Paid holidays

Vacation

Sick days

Job summary

Aquestive Therapeutics is recruiting a Therapeutic Specialty Representative (TSR) to launch Anaphylm, a potential FDA-approved, needle-free epinephrine product, by educating providers and building clinical relationships.

The TSR will develop strategic territories, deliver compliant clinical education, navigate payer landscapes, and drive adoption through pull-through while maintaining strict PDMA and promotional compliance.

Qualifications

• Bachelor's degree required.
• 3+ years of pharmaceutical, specialty, or B2B sales with a track record of exceeding targets.
• Deep understanding of payer coverage and prior authorization workflows.
• Strong analytical skills to translate data into territory strategies.
• Willingness to travel overnight up to 30%.

Responsibilities

• Design and execute strategic territory plans to identify high-potential accounts and drive market penetration.
• Deliver compelling clinical education and build trust with prescribers and healthcare stakeholders.
• Navigate payer coverage dynamics and collaborate with Market Access to overcome barriers.
• Maintain compliant, PDMA–focused promotional activities and accurate CRM documentation.
• Serve as the eyes and ears of the organization, sharing insights to inform strategy.

Skills

Pharma sales

Analytical skills

Payer navigation

Travel 30%

Education

Bachelor's degree

Job description

Aquestive Therapeutics is recruiting a Therapeutic Specialty Representative (TSR) to launch Anaphylm, a potential FDA-approved, needle-free epinephrine product, by educating providers and building clinical relationships.

The TSR will develop strategic territories, deliver compliant clinical education, navigate payer landscapes, and drive adoption through pull-through while maintaining strict PDMA and promotional compliance.